{
  "symbol": "MRUS",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "clinical-stage developments"],
    "riskScore": 7,
    "reason": "Merus N.V. operates in the biotechnology sector, which is prone to speculation due to its clinical-stage developments and potential for breakthrough therapies."
  }
}